Matthew Ayre

Matthew Ayre, MPharm, MRPharmS


If you made any changes in Pure these will be visible here soon.

Personal profile


2021: Doctor of Philosophy (PhD) currently studying, The University of Manchester

2021: Registration with General Pharmaceutical Council

2020: Provisional registration with General Pharmaceutical Council

2019: Master of Pharmacy (MPharm), The University of Manchester 

Research interests

  • Mental health patient safety - primary and secondary care
  • Psychotropic medication use and safety
  • Appropriate prescribing and monitoring of psychotropics
  • Medication errors (prescribing, monitoring, dispensing, and administration)
  • Adverse drug events
  • Epidemiology and aetiology of medication safety issues for patients with mental illness

Memberships of committees and professional bodies

Registered General Pharmaceutical Council (GPhC)

Member Royal Pharmaceutical Society (RPS)

Associate Member College of Mental Health Pharmacy (CMHP)

Member British Association for Psychopharmacology (BAP)

Pharmacist's Defence Association (PDA)

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Education/Academic qualification

Master of Pharmacy, MPharm

21 Sep 201525 Jun 2019

Award Date: 25 Jun 2019

Areas of expertise

  • RM Therapeutics. Pharmacology
  • RS Pharmacy and materia medica


Dive into the research topics where Matthew Ayre is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles